Robert Tarran Ph.D.

Professor, UNC at Chapel Hill

Dr. Tarran received his BSc (hons) from The University of Leeds, UK and his PhD in Physiology from Newcastle University. Prior to joining the faculty at UNC-Chapel Hill, he completed post-doctoral research in ion channel physiology at the University of North Carolina at Chapel Hill and the University of California at Berkley. Dr. Tarran's research interests have centered on the role of ion channels in chronic lung diseases including CF, COPD and asthma. During his career, Dr. Tarran has significantly contributed to the establishment of confocal microscopy measurements of airway surface liquid height as a method for studying airway epithelial function. Dr. Tarran is also the founder of Spyryx Biosciences, which is based on his discovery of the SPLUNC1/ENaC regulatory pathway in the respiratory tract. Dr. Tarran is currently a Professor in the Department of Cell Biology and Physiology at UNC-Chapel Hill, a member of the Lineberger Cancer Center, and a member of the Cystic Fibrosis Center/Marsico Lung Institute.